UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 8-K

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report: April 12, 2007

(Date of earliest event reported)

 

KIMBERLY-CLARK CORPORATION

(Exact name of registrant as specified in its charter)

 

 

Delaware

1-225

39-0394230

 

 

(State or other jurisdiction

(Commission File

(IRS Employer

 

of incorporation)

Number)

Identification No.)

 

 

 

P.O. Box 619100, Dallas, Texas

75261-9100

 

(Address of principal executive offices)

(Zip Code)

 

 

(972) 281-1200

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17

 

CFR 240.14d-2(b))

 

o Pre-Commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4))

 


 

Item 7.01 Regulation FD Disclosure.

 

Attached hereto as Exhibit 99 is a summary that reflects reclassifications in the composition of Kimberly-Clark Corporation’s (the “Corporation”) Health Care and K-C Professional & Other business segments. The Corporation’s scientific business was moved from the Health Care segment to the K-C Professional & Other segment effective January 1, 2007 to reflect the current management responsibility for that business. The summary includes the effect of the reclassifications for each segment on the following: Net Sales and Operating Profit for the full years 2004 and 2005 and by quarter for 2006, and Depreciation and Amortization Expense, Assets and Capital Spending for 2005 and 2006.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit 99

Net Sales and Operating Profit (as reclassified) for the full years 2004 and 2005 and by quarter for 2006, and Depreciation and Amortization Expense, Assets and Capital Spending (as reclassified) for 2005 and 2006 of the Corporation’s Health Care and K-C Professional & Other business segments.

 


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

KIMBERLY-CLARK CORPORATION

 

 

Date: April 12, 2007

By:

/s/: Mark A. Buthman

 

Mark A. Buthman

 

Senior Vice President and

 

Chief Financial Officer

 

 


 

EXHIBIT INDEX

 

Exhibit 99

Net Sales and Operating Profit (as reclassified) for the full years 2004 and 2005 and by quarter for 2006, and Depreciation and Amortization Expense, Assets and Capital Spending (as reclassified) for 2005 and 2006 of the Corporation’s Health Care and K-C Professional & Other business segments.

 

 


Exhibit (99)

 

NET SALES AND OPERATING PROFIT BY BUSINESS SEGMENT

(as reclassified)

 

 

 

 

Net Sales

 

 

 

K-C

 

 

 

 

 

 

Professional

 

 

 

($ millions)

 

 

& Other

 

 

Health Care

 

 

 

 

 

 

 

2004 Year

 

$

2,826.7

 

$

1,131.2

2005 Year

 

 

2,672.2

 

 

1,149.6

2006

 

 

 

 

 

 

1st Quarter

 

 

652.8

 

 

300.5

2nd Quarter

 

 

704.0

 

 

317.8

3rd Quarter

 

 

717.5

 

 

308.2

4th Quarter

 

 

738.8

 

 

310.9

 

 

 

 

 

 

 

Year

 

$

2,813.1

 

$

1,237.4

 

 

 

 

Operating Profit

 

 

 

K-C

 

 

 

 

 

 

Professional

 

 

 

($ millions)

 

 

& Other

 

 

Health Care

 

 

 

 

 

 

 

2004 Year

 

$

411.5

 

$

245.1

2005 Year

 

 

472.8

 

 

200.4

2006

 

 

 

 

 

 

1st Quarter

 

 

104.5

 

 

51.3

2nd Quarter

 

 

113.9

 

 

58.3

3rd Quarter

 

 

127.2

 

 

51.4

4th Quarter

 

 

126.5

 

 

50.2

 

 

 

 

 

 

 

Year

 

$

472.1

 

$

211.2

 

Note:

There is no change to previously reported amounts for the Personal Care and Consumer Tissue segments or Corporate & Other.

 


DEPRECIATION AND AMORTIZATION EXPENSE, ASSETS, AND CAPITAL SPENDING

BY BUSINESS SEGMENT

(as reclassified)

 

 

 

 

K-C

 

 

 

 

 

 

Professional

 

 

 

($ millions)

 

 

& Other

 

 

Health Care

 

 

 

 

 

 

 

Depreciation and Amortization

 

 

 

 

 

 

2005

 

$

135.7

 

$

52.4

2006

 

 

126.3

 

 

40.3

 

 

 

 

 

 

 

Assets

 

 

 

 

 

 

2005

 

 

2,540.4

 

 

2,038.5

2006

 

 

2,593.2

 

 

2,169.7

 

 

 

 

 

 

 

Capital Spending

 

 

 

 

 

 

2005

 

 

87.7

 

 

27.3

2006

 

 

131.1

 

 

40.1

 

Note:

There is no change to previously reported amounts for the Personal Care and Consumer Tissue segments or Corporate & Other.